Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ascendis Pharma A/S (ASND) vs Teradyne, Inc. (TER) Price & Performance

Ascendis Pharma A/STrade
Teradyne, Inc.Trade

Price performance (Past 24H)

Key statistics

Ascendis Pharma A/S vs Teradyne, Inc. — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Teradyne, Inc. trades at $388.77 (market cap $59.34B). The key difference: Teradyne, Inc. is far larger — about 3.6× Ascendis Pharma A/S's market cap, and Teradyne, Inc. pays a 0.14% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.

ASNDTER
Market Cap
$16.67B$59.34B
Sector
HealthTechnology
52-Week High
$277.18$483.84
52-Week Low
$189.74$109.30
Enterprise Value
$17.04B$59.09B
Dividend Yield
0.14%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Read more on ASND

About Teradyne, Inc.

Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.

Read more on TER